This database tracks 16 cardiac surgery products from 11 manufacturers operating in the Chinese medical robotics market. Of these, 7 have received NMPA clearance. Browse the listing below for technical details, regulatory status, and manufacturer information.
Specialties
· 16 products · 11 companies · 7 NMPA-cleared
Cardiac Surgery
Products
PRODUCTS · RainMed Medical
FlashAngio caIMR System
Non-invasive coronary microcirculation diagnostic system measuring IMR without guidewires or hyperemic agents.
read more ›PRODUCTS · RainMed Medical
FlashBot Vascular Interventional Surgery Robot
Platform-level vascular interventional surgical robot integrating diagnostic AI with robotic catheter manipulation for …
read more ›PRODUCTS · Jieruo Medical
Jieruo Vascular Interventional Robot
First-generation PCI surgical robot from Jieruo Medical featuring sub-millimeter precision for coronary stent placement …
read more ›PRODUCTS · Sonosemi Medical
LiqMagic Coronary Intravascular Lithotripsy System
Coronary intravascular lithotripsy (IVL) system for treating calcified coronary artery lesions, NMPA approved October …
read more ›PRODUCTS · Abrobo
PANVIS Star Pan-Vascular Interventional System
Next-generation pan-vascular interventional robot from Abrobo covering coronary, peripheral, and neurovascular …
read more ›PRODUCTS · CathBot
R-ONE Vascular Intervention Surgical Robot
Coronary PCI surgical robot with biomimetic dual-hand control, first commercially available interventional cardiology …
read more ›Companies
- Aopeng Medical Shanghai, China
- Stereotaxis St. Louis, Missouri, USA
- Hanglok-Tech Zhuhai (Hengqin), China
- MEIO CardiNav Shaoxing, China
- Zhongke Hongtai Beijing, China
- WeMed Beijing, China
- RainMed Medical Zhuhai, China
- Jieruo Medical Shanghai, China
- Sonosemi Medical Shenzhen, China
- Abrobo Shenzhen, China
- CathBot Shanghai, China